Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine
- PMID: 18845981
- DOI: 10.1097/INF.0b013e31817e5188
Five-fold increase in pediatric parapneumonic empyema since introduction of pneumococcal conjugate vaccine
Abstract
A retrospective review of medical records for all pediatric parapneumonic empyema (PPE) patients admitted to our hospital from 1996 to 2006 revealed that PPE increased 5-fold in the post-heptavalent pneumococcal conjugate vaccine (PCV7) period (2001-2005) relative to the pre-PCV7 period (1996-2000), from 13 cases to 65. Most of this increase was associated with culture-negative empyema, which accounted for 61% of all post-2000 cases; 19% was culture-positive pneumococcal empyema. Our analysis indicates that non-PCV7 serotypes became more prevalent at our institution after introduction of the vaccine.
Similar articles
-
Impact of the pneumococcal conjugate vaccine on pneumococcal parapneumonic empyema.Pediatr Infect Dis J. 2006 Mar;25(3):250-4. doi: 10.1097/01.inf.0000202137.37642.ab. Pediatr Infect Dis J. 2006. PMID: 16511389
-
Changing characteristics of invasive pneumococcal disease in Metropolitan Atlanta, Georgia, after introduction of a 7-valent pneumococcal conjugate vaccine.Clin Infect Dis. 2007 Jun 15;44(12):1569-76. doi: 10.1086/518149. Epub 2007 May 8. Clin Infect Dis. 2007. PMID: 17516400
-
Pneumococcal bacteremia among infants with fever without known source before and after introduction of pneumococcal conjugate vaccine in the Basque Country of Spain.Pediatr Infect Dis J. 2007 Aug;26(8):667-71. doi: 10.1097/INF.0b013e3180f610b3. Pediatr Infect Dis J. 2007. PMID: 17848875
-
The epidemiology of childhood pneumococcal disease in the United States in the era of conjugate vaccine use.Infect Dis Clin North Am. 2005 Sep;19(3):629-45. doi: 10.1016/j.idc.2005.05.008. Infect Dis Clin North Am. 2005. PMID: 16102653 Review.
-
Epidemiology of invasive pneumococcal disease in the Arabian Peninsula and Egypt.Int J Antimicrob Agents. 2009 May;33(5):410.e1-9. doi: 10.1016/j.ijantimicag.2008.08.012. Epub 2008 Oct 30. Int J Antimicrob Agents. 2009. PMID: 18976887 Review.
Cited by
-
Update on the success of the pneumococcal conjugate vaccine.Paediatr Child Health. 2011 Apr;16(4):233-40. doi: 10.1093/pch/16.4.233. Paediatr Child Health. 2011. PMID: 22468128 Free PMC article.
-
Pediatric invasive pneumococcal disease in the United States in the era of pneumococcal conjugate vaccines.Clin Microbiol Rev. 2012 Jul;25(3):409-19. doi: 10.1128/CMR.00018-12. Clin Microbiol Rev. 2012. PMID: 22763632 Free PMC article. Review.
-
A challenging case of thoracic empyema caused by Prevotella spp.Respir Med Case Rep. 2021 Dec 15;35:101567. doi: 10.1016/j.rmcr.2021.101567. eCollection 2022. Respir Med Case Rep. 2021. PMID: 34976719 Free PMC article.
-
Increased paediatric hospitalizations for empyema in Australia after introduction of the 7-valent pneumococcal conjugate vaccine.Bull World Health Organ. 2013 Mar 1;91(3):167-73. doi: 10.2471/BLT.12.109231. Epub 2012 Dec 11. Bull World Health Organ. 2013. PMID: 23476089 Free PMC article.
-
Community-Acquired Pneumonia in the Conjugate Vaccine Era.J Pediatric Infect Dis Soc. 2012 Dec;1(4):314-28. doi: 10.1093/jpids/pis101. Epub 2012 Nov 6. J Pediatric Infect Dis Soc. 2012. PMID: 26619424 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical